Search

everythinglearnresearchcommunity

for

Search:↓

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Ocrelizumab may cause pancreatitis in some patients.

Patients with alopecia areata using Janus kinase inhibitors are not following lab monitoring guidelines.

Erlotinib can cause excessive eyelash growth.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.